SCHEMBL2808697

SCHEMBL2808697

C/C(=C\Oc1ccc(Oc2ccccc2)cc1)C(=O)Nc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
ALDH1A1 P00352 5/20 0.51
TGM2 P21980 1/20 0.50
EPHX1 P07099 1/20 0.50
PGR P06401 1/20 0.49
NPC1 O15118 2/20 0.48
CRHBP P24387 1/20 0.48
RAB9A P51151 1/20 0.48
CRHR2 Q13324 1/20 0.48
RNF4 P78317 1/20 0.47
LMNA P02545 2/20 0.45
POLB P06746 1/20 0.45
HTT P42858 1/20 0.45
MAPT P10636 1/20 0.45
THRB P10828 1/20 0.45
PDK1 Q15118 1/20 0.45
PDK2 Q15119 1/20 0.45
PDK3 Q15120 1/20 0.45
PDK4 Q16654 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2808701 1.00 HPGD (0.53) HPGDSMN1; SMN2ALDH1A1TGM2EPHX1
SCHEMBL2811474 0.94 NAPRT (0.48) HPGDSMN1; SMN2ALDH1A1EPHX1NPC1
SCHEMBL2811479 0.94 NAPRT (0.48) HPGDSMN1; SMN2ALDH1A1EPHX1NPC1
SCHEMBL2811502 0.88 KMT2A (0.47) HPGDSMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL2807812 0.88 PTPN1 (0.50) SMN1; SMN2ALDH1A1RAB9APOLBHTT
SCHEMBL2810919 0.88 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1NPC1RAB9ALMNA
SCHEMBL2810917 0.88 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1NPC1RAB9ALMNA
SCHEMBL2811497 0.88 KMT2A (0.47) HPGDSMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL2807815 0.88 PTPN1 (0.50) SMN1; SMN2ALDH1A1RAB9APOLBHTT
SCHEMBL2809947 0.87 RAB9A (0.54) SMN1; SMN2ALDH1A1NPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 HPGD 2145/4885SMN1; SMN2 1135/4885ALDH1A1 405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.